pH-Responsive Erdafitinib Liposomes with FGFR3 Targeting for Intravesical Bladder Cancer Therapy. Liang H, Li G, Zhang W, Wang W, et al. Int J Mol Sci 2026;27:9014.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liang H, Li G, Zhang W, Wang W, et al. pH-Responsive Erdafitinib Liposomes with FGFR3 Targeting for Intravesical Bladder Cancer Therapy. Int J Mol Sci 2026;27:9014.
PMID: 42941789